and under what circumstances? In this paper, we describe the insurance, reimbursement, and access rules in the American medical care system. We present broad outlines of the system for everyone in the United States. Because the system is so heterogeneous, we focus particular attention on the system for the elderly. We note where research has explored a link between system provisions and outcomes, but we do not take the further step of relating system provisions to health outcomes in any systematic way.
We begin in the next section by presenting a brief overview of medical systems in developed countries. We show the large differences in medical spending and health outcomes across countries that motivate our desire to make system comparisons. The second section discusses the methods through which Americans get insurance coverage and the flow of money. Section three highlights the reimbursement arrangements that providers operate under, and the fourth section presents the access rules for patients and providers. We end with a brief conclusion.
I. The International Experience
The performance of medical care systems differs enormously across countries.
To give a summary of this performance, we emphasize two dimensions most relevant for economic analysis: how much the system costs, and how healthy people are, perhaps as a result of the medical system.
1
To measure costs, we look at medical spending as a share of GDP. GDP is a natural scalar by which to evaluate medical care; a richer country should spend more on medical care than a poorer country. In principle, a more accurate scalar would be the 1 Other dimensions of performance include the degree to which the system treats people fairly and the extent to which it upholds normative values of right and wrong. We are less able to measure these dimensions quantitatively.
amount of medical spending that is expected, given the income elasticity of medical care.
That elasticity is not known, however. In micro data, the elasticity of medical spending with respect to income is far below 1, generally about .2 (Newhouse et al., 1993) . This suggests that we should look at per capita spending more than spending relative to GDP. This comparison, however, presumes that prices are constant across countries at a point in time. In fact, medical prices rise with income (Baumol, 1967) . In macro regressions, the income elasticity is usually somewhat above 1 (Getzen, 2000) . But that is likely overstated, as it reflects demand as well as technology conditions. There is no obvious scalar, so we focus on the GDP comparison. Figure 2 shows medical spending as a share of GDP in OECD countries. The data are for 1998, the most recent year in which they are complete. The United States spends the most of any country on medical care, nearly 14 percent of GDP. The next highest country, Switzerland, spends only 11 percent of GDP on medical care. Among high income countries, the UK is a very low outlier, spending only 7 percent of GDP on medical care. The average in the OECD is about 8 percent.
To measure health, we use life expectancy at birth. Life expectancy is the most common summary of health in the literature. In using this indicator, we emphasize immediately that it is influenced by far more than medical care. Life expectancy is affected by lifestyle factors (smoking, diets), environmental conditions (air pollution), and other economic and social factors. Our purpose here is not to grade medical systems.
Rather, we want to illustrate the range of variation in the data.
Life expectancy in OECD countries is shown in figure 3. Once again, there is wide variation. The mean across developed countries is 77 years. The United States, although with a life expectancy of 77 years (equal to the mean), ranks 21 of the 30 countries shown in the figure. Japan is the clear positive outlier, with life expectancy of 81 years.
Comparing figures 2 and 3 suggests little correlation between medical spending and life expectancy. Figure 4 shows this explicitly. The horizontal axis of the figure is medical spending as a share of GDP. The vertical axis is life expectancy. A regression line indicates a positive relation between the two, although this is driven primarily by the very low income countries (Turkey, Hungary, and the Slovak Republic). Among higher income countries, there is no relation between spending and health outcomes.
As we indicated above, we do not interpret this result as suggesting that the marginal value of medical care is low. That may be the case, but it is not proven by this comparison. Rather, the comparison illustrates the need to explore the issue further.
What role do medical systems play in influencing these outcomes? Do system features relate to performance? The remaining sections of the paper start down this path.
II. Insurance Coverage in the United States
Health insurance in the United States is provided through a mixture of public and private programs. The principle public plans are Medicare, which provides care for the elderly and some disabled non-elderly, and Medicaid, which provides care for poor women and children under 65, the blind and disabled, and long-term care for persons age 65 and older. Employer-provided plans are the principle source of care for the nonelderly. We focus on care for the elderly but we begin by describing how care for the elderly fits into the total health care system. A large proportion of out-of-pocket payments are for out-patient prescription drugs. In addition, much long-term care spending is out of pocket, although these expenses are undercounted in this table.
In the non-elderly population, about 50 percent of medical payments are made by private insurers. Government payments account for 17 percent of spending, and out-ofpocket spending by individuals account for another 21 percent.
A.
Who Pays for Insurance?
Inpatient insurance (Part A) under Medicare is paid for by the "young" through a 2.9% payroll tax -half of which is paid for by the employer and half by the employee. Insurance premiums under employer-provided plans for the non-elderly are typically shared between the employer and the employee. On average, about 75 to 80 percent of premiums are paid for by the employer and the remainder by the employee.
Unlike wages and salaries, compensation to employees in the form of health insurance is not taxed. Thus employees have a strong incentive to take compensation in the form of health insurance (Feldstein, 1973) . And, employees have a strong incentive to encourage generous insurance plans with low out-of-pocket co-payments, which are typically taxed.
Thus for the under 65 group as well, part of the system pushes toward first dollar coverage with little constraint on expenditure at the time care is received.
The out-of-pocket bill facing individuals is the direct spending on medical care services plus the family cost of health insurance. These totals are not readily apparent in Table 1 , which records the payer at the time the service is used. To flow through these insurance payments to individuals, Table 2 shows family spending on medical care.
Among the elderly population, insurance payments are about $1,800 per family (largely for supplemental Medigap insurance coverage and the employee part of employer-sponsored retirement coverage), and direct costs are about the same magnitude. The amounts are similar in the non-elderly population, about $1,900 for direct payments and health insurance.
In addition to these payments, the non-elderly also pay indirectly for the employer's portion of employer-provided health insurance. Though the employer writes the check for insurance, economic research establishes quite clearly that the ultimate incidence of these payments is on workers (Summers, 1989; Gruber, 1994) . A rough guess of these amounts is about $2,700 per family. Spending on health insurance and medical care is thus perhaps $4,500 in total for the non-elderly population.
The final set of payments are taxes to pay for public programs, and the implicit income that retirees give up earlier in life to pay for employer-provided medical care when retired. The incidence of these payments by age is somewhat harder to assess.
Previous taxes paid by the elderly for Medicare do not cover their current use, for example, and so some of that cost is paid for by the current young. The same is likely true with employer-provided supplemental insurance. Rather than deal with these generational incidence questions, however, we limit ourselves to payments targeted to immediate services use.
B. Gradations in Insurance Coverage
To this point, we have treated all private health insurance as identical. In practice, there are enormous differences in the type of insurance that people have. The services covered by Medicare differ from those covered by Medicaid and private insurance. Medicaid covers the range of acute and long-term care services. On paper,
Medicaid is among the most generous insurance plans available. In practice, though, Medicaid payments are so tightly constrained that access to care for Medicaid beneficiaries is a significant concern. We do not focus greatly on the Medicaid program in the remainder of the paper.
The Medicaid experience raises the broader point that access is not just about covered services. There is some managed care in Medicare, but it is decidedly less important. 
III. Reimbursing Providers
Given the many different ways that Americans obtain health insurance, it is not surprising that there is a wide range of reimbursement systems in use. Further, the reimbursement systems differ enormously in the incentives they provide.
Perhaps the most critical feature of reimbursement systems is the degree to which payments are related to costs. Some reimbursement systems pay more when more care is provided, and others pay less. Consider a linear relation between payment for a service provided and the various costs of that service:
(1) Payment = a + b * Practice Cost + c * Time cost where a, b, and c are parameters of the payment system. Practice costs include office expenses, non-physician administrative personnel, malpractice insurance, and supplies.
The time costs represent the opportunity costs of the physician devoting additional hours to care.
Historically, medical care in the United States was paid for on a fee-for-service basis. In this system, total reimbursement is equal to the cost of care provided (with some division between insurer and enrollee payments. In terms of equation (1), a=0, b=1, and c=1. Fee-for-service insurance is shown at one end of the scale of payment generosity in Figure 6 .
There is a distinction between marginal and average cost that is important in understanding the incentives of fee-for-service systems. Medical care has very high fixed costs, but the marginal cost of additional production is often low. For example, it costs about $800 million to develop a new drug (DiMasi, 2003) , but the cost of producing additional pills once the drug is developed is only pennies. Similarly, many of the costs for a physician are sunk costs -the opportunity cost of medical education most particularly. Other costs are fixed costs, depending only on the decision to practice medicine. Examples of these costs include malpractice insurance, office rent, and equipment overhead. True marginal cost is low.
Traditional fee-for-service payment systems paid on the basis of average costs.
This reimburses physicians for sunk and fixed costs as well as marginal costs. In practice, this creates large profits for providing additional care, because payment far exceeds costs at the margin. Thus, fee-for-service payment systems strongly encourage provision of medical care in almost all circumstances.
A somewhat less generous set of incentives is provided by a salary system. In many HMOs in the United States and in some European countries, physicians are paid a salary for providing care. The salary system corresponds to a payment rule where a>0, b=1, and c=0. The physician earns a fixed amount of money and does not have to pay for any practice expenses, but is not reimbursed more for additional time costs.
The salary system provides fewer incentives for care provision than does the feefor-service system. In a salary system, additional care provided is not reimbursed at the margin, so there is no financial incentive to do more. In particular, because the doctor's time cost is not reimbursed at the margin, the doctor has an incentive to cut back on time inputs. A doctor on a salary earns the same amount if he shows up for a full day or half day of work (assuming his salary is not docked). Thus, doctors will attempt to 'arrive late and leave early,' and to substitute tests and devices for additional time.
The ability of physicians to do this varies by setting. In some countries, such as Italy, monitoring of physicians is poor, and doctors routinely violate the guidelines as to hours that must be worked . In many HMOs, in contrast, monitoring is stronger, and physicians are not able to shirk.
The third type of payment system is capitation. In the extreme version of this system, physicians are paid a fixed amount, and must pay for all care provided out of the capitation amount. In terms of equation (1), a>0, b=0, and c=0. This type of system is most common with primary care physicians. If a patient of a doctor paid this way uses medications that the doctor prescribes or is admitted to the hospital, the costs of the medications or hospitalization are paid for out of the capitation amount.
There are a complex array of capitation systems used in practice. Some physicians are capitated for care used in the primary setting, medications, and nonemergency hospitalizations, but not for emergency hospitalizations. Others are capitated for all costs, but have reinsurance for very expensive patients. Still others have varying degrees of capitation depending on total spending in the practice as a whole.
Regardless of the specifics, capitated systems have the feature that physician earnings are negatively related to the amount of care provided. Doctors that do more earn less. Not surprisingly, the incentives of this system are the weakest (as shown in figure   6 ). A purely profit maximizing doctor paid a capitation rate would not see patients at all and would not provide any care. Of course, HMOs monitor physician behavior, and patients will find other doctors if no care is provided, meaning that future income will decline. Thus, the example is grossly exaggerated. But it shows the nature of the incentives.
In addition to varying across payers, reimbursement systems in the United States have changed over time. Figure 6 illustrates the evolution of these systems. Historically, both Medicare and private insurers reimbursed services on a fee-for-service basis. The reason for this was practical. When private insurers started to cover medical care, they did not know how to pay for care; medical care was separate from insurance. Doctors had list prices, however, and so insurers paid those prices. This ultimately turned into the fee-for-service system.
Over time, both Medicare and the private sector have moved away from fee-forservice payment. Medicare currently pays physicians on a fee schedule, based loosely on the estimated cost of services provided. In a number of detailed studies, the government attempted to determine the cost of different services, and now reimburses physicians on that basis. The payment is still per service performed, but is somewhat less generous than it once was.
Bigger changes have occurred in the payment system for hospitals. Since the early 1980s, payment for Medicare patients admitted to hospitals has been under a partially capitated system termed the Prospective Payment System, or PPS. When a Medicare patient is admitted to a hospital, the hospital reports the diagnosis the patient received and whether a surgical procedure was performed or not. These two attributes are used to classify patients into one of about 470 Diagnosis Related Groups, or DRGs.
The payment received for the patient depends only on the DRG, not the specific services provided (other than how the surgical/non-surgical distinction affects DRG coding).
An example illustrates how this system works. Consider the treatment of patients with acute myocardial infarction, or heart attack (see Cutler and McClellan, 1996) . A patient with a heart attack will almost always be admitted to a hospital. Upon admission, the hospital will administer a number of medications, including aspirin, beta blockers, and potentially thrombolytics. Under the old fee-for-service payment system, each of these medications would be reimbursed separately. In the DRG system, there is no additional payment for providing them.
Many patients with a heart attack receive cardiac catheterization, a diagnostic procedure that measures the extent of blood flow to the heart. Catheterization is a surgical procedure; hence patients receiving a catheterization will be in a different DRG than patients who do not receive catheterization. The exact cost of the catheterization is not a factor in payment, however; a hospital that takes longer for each catheterization will receive no more money than a hospital that takes less time.
Depending on the results of the catheterization, additional procedures may be performed. Bypass surgery is a procedure to reroute blood flow around the blocked area in the coronary arteries. Angioplasty is used to clear the original blockage and restore blood flow in the arteries. Each of these procedures moves the patient into a more highly reimbursed DRG. But the specifics of the services provided -the type of catheter, the number of recovery days in the hospital, and the follow-up tests, are not reimbursed separately.
In the DRG system, therefore, heart attack patients will be classified into one of four DRG groups: those medically managed only (without any surgical procedures); those who receive cardiac catheterization but not bypass surgery or angioplasty; those who receive bypass surgery; and those who receive angioplasty. 3 The incentives of this system are therefore relatively strong to perform surgery, but weak to perform additional non-surgical care in hospitals.
In the private sector, reimbursement is more variable. Some physicians are paid on a fee-for-service basis, although usually one where the payments are substantially less generous than they were formally. More common is for physicians to be paid on a salary basis, or by full or partial capitation. Hospital payments are generally along the lines of Medicare, with a payment per admission (using the DRG system) or per day of care received (a per diem system). In the latter methodology, the payment does not vary with the services provided in each day. Thus, intensive care in the stay is discouraged, while marginal days of care are not so heavily penalized. For both hospitals and physicians, the rate of payment is generally lower in the private sector than in Medicare. As a result, the incentives for limited service provision are even stronger.
A. Evidence on Reimbursement Incentives
How much do these incentives matter? A large literature has examined the response of services provided to physician payment incentives (see Cutler Evidence from managed care in the private sector shows major reductions in hospitalization rates and lengths of hospital stay in response to those incentives (Glied, 2000) . Admission rates in managed care plans are well below rates in fee-for-service plans, and lengths of hospital stay are shorter as well. The total saving in hospital care is about 20 percent. Some of this difference is certainly due to reimbursement incentives, although direct regulations on use of care (described in the next section) are important too.
Overall, the United States medical care system has become substantially less generous in payment for care in the past two decades, and this has affected the care provided. How the incentives in the US system compares to other countries, however, is not generally known.
IV. Access Rules
Access rules are among the most complex areas of medical care. There are myriad varieties of medical services that can be provided, with different rules for each.
For example, patients may have different access to primary care, mental health specialists, and orthopedists. We synthesize the access rules in three parts. The set of services covered by insurance is the first element. Are prescription medications covered by the policy or not? We discussed variations in coverage above. We focus here on two other parts of access: financial payments that individuals have to make when they use care (termed cost sharing); and non-financial barriers to the use of services.
A. Cost Sharing in Insurance
All insurance policies require patients to pay something when they access care.
Cost sharing evolved as a way to limit moral hazard -excessive use of medical services only because they are insured. Since its beginnings, cost sharing has become much more elaborate.
Traditionally, private insurance policies had a varying schedule of patient payments. A typical private schedule is shown in figure 8 . The deductible is the amount that a patient paid before insurance covered any care. A typical insurance policy had a deductible of about $500. After the deductible, costs were split between the insurer and the enrollee. The share of enrollee payments is termed the coinsurance rate; a standard coinsurance rate was 20 percent. Coinsurance would continue until the patient reached a specified maximum, termed the stop-loss. Past this point, the insurer would pay all the costs of medical care. A common stop-loss was about $1,500.
The optimal insurance policy balances risk sharing against moral hazard. Making individuals pay more for medical care reduces the amount of moral hazard. But it also increases the financial risk that people are exposed to. In the optimal policy, these gains and losses are equal at the margin -a small increase in coinsurance rates leads to as much loss from increased risk as it brings in benefits from reduced moral hazard.
In practice, the tax system subsidized generous insurance, and thus tilted policies towards being overly generous (Feldstein, 1973) . Employer-payments for health insurance are not counted as income for tax purposes, while individual payments are. It was noted above that this provides incentives for people to have employer-based policies rather than individual policies. In addition, it encourages running as much money as possible through insurance rather than leaving costs to be paid for out-of-pocket, since insured services are paid for with pre-tax dollars rather than post-tax dollars. This leads to a welfare loss -too little moral hazard, and not enough risk sharing.
A substantial literature has examined the impact of this tax subsidy on overall medical spending and the losses to the economy. Martin Feldstein pioneered these calculations in the 1970s, and since then others have pursued this line of analysis.
Determining a final value for the impact of the tax subsidy on spending is complex, since the chain of causal events is long. The tax subsidy influences the structure of insurance policies, which in turn affects how much care people use, and thus medical spending. A consensus estimate is that total medical spending is perhaps 5 to 10 percent higher as a result of the tax subsidy .
The traditional Medicare program has the opposite problem. Cost sharing in the Medicare system is very high, particularly for catastrophic expenses. It was already noted that Medicare does not cover outpatient prescription medications, leading beneficiaries to face substantial risk. In addition, cost sharing for the set of covered services is high. Table 4 shows the cost sharing provisions in Medicare in detail, and figure 8 shows the schedule of payments for a 'typical' enrollee. 4 Beneficiaries who use outpatient services have a deductible of $100 and a 20 percent coinsurance rate above that. The $100 deductible is not particularly large, but the coinsurance occurs without limit. This exposes Medicare beneficiaries to substantial risk -far more than in the private sector. Hospital cost sharing is also perverse. Medicare beneficiaries face a deductible equal to one day of hospital care, about $800 currently. This is very high by private standards. After the deductible is paid, Medicare pays for the entire amount for the next 60 days of care. Beyond the 60 day window, beneficiaries face increasing amounts of cost sharing for the next 30 days, and then no further government reimbursement, 5 again exposing beneficiaries to large financial risk. By any calculation, the traditional Medicare program leaves people with far more financial risk than is optimal.
In response to this high degree of risk bearing, it is natural for Medicare beneficiaries to want more coverage than Medicare provides. For the low income population, Medicaid provides this additional insurance, paying for the cost sharing required by the perverse Medicare reimbursement schedule.
The higher income population does not qualify for Medicaid, but receives supplemental coverage in other ways. Some employers provide retiree health benefits that pay for the cost sharing required by Medicare. Others purchase individual insurance policies that supplement Medicare, termed "Medigap" insurance. Still others enroll in HMOs, which have lower cost sharing. All told, about three-quarters of the elderly have some supplemental insurance, through Medicaid or private supplements.
Both employer and individual supplements provide first dollar coverage -there is generally no cost sharing for hospital or physician services. The reason why first dollar coverage is the norm is subtle. First dollar coverage clearly leads to moral hazard. But a lot of the additional utilization is paid for by the traditional Medicare program, not the supplemental insurance. A beneficiary that goes to the doctor more as a result of having supplemental insurance pays for only 20 percent of the additional use in the insurance premium; the remaining 80 percent is covered by Medicare.
As a result, the cost of Medicare is much higher than it would be without supplemental insurance. Estimates suggest that people who have supplemental insurance cost Medicare about 20 percent more than they would without supplemental coverage (Christensen and Shinogle, 1997) . Of course, a better number to know is the additional spending beyond what Medicare would optimally spend if it were configured with the most appropriate degree of cost sharing. Since the optimal policy is more generous than the current policy, the savings from the optimal policy are lower. There are no estimates of these savings, however.
B. Non-financial Restrictions
All insurance plans impose some non-financial barriers to access medical care.
People need physician approval before they can receive prescription medications or be admitted to a hospital, for example. But some plans have additional barriers to the use of care.
In the Medicare program, there are essentially no barriers to the use of care.
Patients can see whatever doctor they want at whatever time they want. Referrals are not required, and no providers are out of bounds. 6 This led to an era of substantial increase in services provided. Recently, reimbursement has moved away from a pure fee-for-service basis into a more capitated basis, providing some incentives for doctors to do less. But the patient side is still very generous.
There are substantially more barriers to receipt of care in private insurance. The most important barriers are in managed care plans. Managed care was noted in passing earlier, but is particularly relevant at this point. We provide a taxonomy of managed care
in Table 5 .
The most limited managed care arrangement is a "managed" indemnity insurance Preferred Provider Organizations (PPOs), a second type of managed care, form a network of providers, including physicians, hospitals, pharmaceutical companies, and others, and control costs by securing discounts from them. The quid pro quo for the discounted fee is that insured participants are steered to in-network providers.
Out-of-network providers may get reduced coverage on a limited basis (with higher cost sharing, for example) or may not be covered at all. In 1991, the typical PPO had an innetwork coinsurance rate of 10 percent and an out-of-network coinsurance rate of 20 percent. PPOs usually impose pre-authorization requirements as well, though they are rarely especially strict. As Figure 9 shows, PPO enrollment, zero in 1980, now makes up about one-quarter of the privately insured population.
Full integration creates the strongest link between insurance and provision. In the United States, these merged entities are called health maintenance organizations (HMOs). example, frequently requires a deductible followed by a 10 to 40 percent coinsurance payment.
The sweeping nature of insurer-provider interactions is indicated by figure 9 (see also Glied, 1998). In 1980, over 90 percent of the privately insured population in the United States was covered by "unmanaged" indemnity insurance. By 1996, that share had shrunk to a mere 3 percent. HMO enrollment of all forms (including POS enrollment) has increased from 8 percent of the population in 1980 (then predominantly group/staff model enrollment) to nearly half of the privately insured population today.
In exchange for tight access restrictions, most HMOs have very low patient cost sharing. A person might face a $10 copayment for seeing a network physician, compared to full price for the first dollar of care in some indemnity insurance plans.
C. The Impact of Non-Financial Restrictions
Managed care clearly reduces utilization of some types of care. Managed care plans have a higher ratio of primary care physicians to specialists than do non-managed care plans (Glied, 2000) . In addition, non-network providers are much less likely to be seen than are network providers. Perhaps most significantly, however, these requirements allow for substantially lower prices paid for medical care. Exact data on prices in different insurance arrangements is not known, but it is not uncommon to find discounts of 30 percent on physician and hospital care for insurance plans with tight networks. These price reductions are a major reason why managed care plans cost less than traditional indemnity insurance plans (Altman, Cutler, and Zeckhauser, 2003) .
Further, the evidence does not suggest large adverse effects of managed care on health outcomes. Some studies find that patients are worse off, some find that they are better off, and most find they are about the same. Summary reviews of the literature suggest no outcome differences between managed care and traditional insurance policies (Miller and Luft, 1997) Even with this profile -cost savings and no adverse impact on health --managed care is not very popular. Utilization review is the aspect of medicine that physicians dislike the most. Doctors feel their professional integrity is challenged by these restrictions and have protested vehemently. Patients do not like managed care either, in large part because of the perception that managed care restricts they care they can receive. The widespread interest in a Patient's Bill of Rights is testament to this concern.
As a result of physician and patient opposition, the extent of utilization review has changed over time. Where utilization review was common in the early 1990s, it is rarer now. Instead, managed care plans have substituted more financial incentives (such as capitation) to encourage physicians to provide less care.
D. Comparisons with Other Countries
Utilization review as we have described it is unique to the United States. But restrictions on utilization are widespread throughout the developed world. In most countries, utilization is restricted through overall limits on the availability of medical services. Canada, for example, imposes very tight controls on the number of hospitals that can acquire expensive new technologies. There is less technology than physicians would use by choice, so some rationing must occur. In practice, the rationing is done by physicians, who decide which patients most need access to the technologies.
The distinction between physician-driven rationing and insurer-driven rationing is fundamental in some ways, but less important in others. Physicians are certainly happier with physician-driven rationing than with insurer-driven rationing, since they make the decisions in one case but have decisions imposed on them in the other. From the social perspective, however, both methods ration access to medical care. The empirical issue is whether that rationing works well, and how much rationing is appropriate. International comparisons of medical care provided under different insurance arrangements should help to answer this question.
V. Conclusion
Because medical care systems are complex, they cannot be easily characterized.
Still, some dimensions of organization are apparent. In this paper, we highlight three important domains of medical care: the rules about coverage, reimbursement between insurers and providers, and access to care.
While there is variability even within the United States, we suggest the following simple summary. Coverage in the United States is spotty -excellent for the elderly, but not guaranteed for the non-elderly. Historically, reimbursement of providers was very generous, and access was open as well. Increasingly, though, the reimbursement and access routes are being restricted, as insurers respond to moral hazard and the demand for cost containment.
The direction the medical system will go in the United States is not clear. Even in the past few years, reimbursement and access rules have changed, and coverage issues have dominated the public agenda. Changes along all three dimensions bear watching.
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